These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8689815)

  • 41. [The pharmacodynamics and pharmacokinetics of furosemide during ordinary life activities and during head-down tilt hypokinesia in a healthy subject].
    Noskov VB; Goncharov IV; Kovachevich IV; Repenkova LG; Kodratenko SN; Starodubtsev AK
    Eksp Klin Farmakol; 1998; 61(4):29-33. PubMed ID: 9783105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery.
    van der Vorst MM; Kist-van Holthe JE; den Hartigh J; van der Heijden AJ; Cohen AF; Burggraaf J
    Br J Clin Pharmacol; 2007 Dec; 64(6):796-803. PubMed ID: 17441933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The evaluation of the diuretic action of parenteral formulations of metolazone.
    Cvetanovic I; Ranade V; Molnar J; Whelton A; Somberg J
    Am J Ther; 2007; 14(1):25-9. PubMed ID: 17303972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.
    Chennavasin P; Seiwell R; Brater DC
    J Pharmacol Exp Ther; 1980 Oct; 215(1):77-81. PubMed ID: 7452492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose dependency of furosemide-induced sodium excretion.
    Andreasen F; Lauridsen IN; Hansen FA; Christensen S; Steiness E
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1182-8. PubMed ID: 2703969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs.
    Adin DB; Taylor AW; Hill RC; Scott KC; Martin FG
    J Vet Intern Med; 2003; 17(5):632-6. PubMed ID: 14529128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.
    Smith DE; Lin ET; Benet LZ
    Drug Metab Dispos; 1980; 8(5):337-42. PubMed ID: 6107232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot randomised controlled trial evaluating the pharmacodynamic effects of furosemide versus acetazolamide in critically ill patients.
    Brown AJ; Cutuli SL; Eastwood GM; Bitker L; Marsh P; Bellomo R
    Crit Care Resusc; 2019 Dec; 21(4):258-64. PubMed ID: 31778632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alternating sequential dosing with furosemide and ethacrynic acid in drug tolerance in the newborn.
    Chemtob S; Doray JL; Laudignon N; Papageorgiou A; Varma DR; Aranda JV
    Am J Dis Child; 1989 Jul; 143(7):850-4. PubMed ID: 2741861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Optimal way of administration of high dose intravenous furosemide - continuous infusion or bolus?].
    Gallusová J; Halačová M; Cerný D
    Vnitr Lek; 2014 Oct; 60(10):885-92. PubMed ID: 25382011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.
    Li T; Lee MG; Chiou WL
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):495-509. PubMed ID: 3806372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamics of 250 mg and 500 mg oral furosemide in peritoneal dialysis
.
    Leclerc S; Laurin LP; Lafrance JP; Lamarche C; Ouimet D; Paquette F; Pichette V; Nadeau-Fredette AC
    Int J Clin Pharmacol Ther; 2019 Dec; 57(12):603-606. PubMed ID: 31657712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population-based meta-analysis of furosemide pharmacokinetics.
    Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
    Biopharm Drug Dispos; 2014 Mar; 35(2):119-33. PubMed ID: 24151207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant.
    Kroboth PD; Bertz RJ; Smith RB
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1047-55. PubMed ID: 8450449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the diuretic effect of furosemide by different methods of administration in healthy dogs.
    Harada K; Ukai Y; Kanakubo K; Yamano S; Lee J; Kurosawa TA; Uechi M
    J Vet Emerg Crit Care (San Antonio); 2015; 25(3):364-71. PubMed ID: 25885944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats.
    Kang MJ; Yoon WH; Kim ON; Lee MG
    J Clin Pharm Ther; 1995 Feb; 20(1):13-21. PubMed ID: 7775609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natriuretic efficiency of frusemide as a consequence of drug input rate.
    Wakelkamp M; Alván G; Paintaud G
    Br J Clin Pharmacol; 1997 May; 43(5):481-91. PubMed ID: 9159563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.